…
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | 33.80M | 23.40M | 72.50M | 87.70M | 92.50M |
| Minority interest | 2.90M | 1.40M | 0.70M | 0.70M | 0.40M |
| Net income | 27.80M | 17.20M | 61.70M | 76.20M | 73.20M |
| Selling general administrative | 65.40M | 71.00M | 70.80M | 86.00M | 71.90M |
| Gross profit | 132.60M | 134.30M | 162.60M | 174.50M | 165.30M |
| Reconciled depreciation | 24.90M | 23.20M | 21.50M | 21.60M | 21.90M |
| Ebit | 36.20M | 46.50M | 73.20M | 88.50M | 93.40M |
| Ebitda | 61.10M | 69.70M | 94.70M | 109.60M | 114.60M |
| Depreciation and amortization | 24.90M | 23.20M | 21.50M | 21.10M | 21.20M |
| Operating income | 39.80M | 45.80M | 73.20M | 88.50M | 93.40M |
| Other operating expenses | 256.60M | 250.40M | 226.20M | 249.70M | 217.80M |
| Interest expense | 2.40M | 1.90M | 0.70M | 0.30M | 0.20M |
| Tax provision | 8.90M | 7.60M | 11.50M | 12.20M | 19.70M |
| Interest income | 0.40M | 0.70M | 1.30M | 0.50M | 0.20M |
| Net interest income | -2.00M | -1.20M | 0.60M | 0.20M | 0.00M |
| Income tax expense | 8.90M | 7.60M | 11.50M | 12.20M | 19.70M |
| Total revenue | 296.40M | 296.20M | 299.40M | 338.20M | 311.20M |
| Total operating expenses | 92.80M | 88.50M | 89.40M | 86.00M | 71.90M |
| Cost of revenue | 163.80M | 161.90M | 136.80M | 163.70M | 145.90M |
| Total other income expense net | -6.00M | -22.40M | -0.70M | -0.80M | -0.90M |
| Net income from continuing ops | 24.90M | 15.80M | 61.00M | 75.50M | 72.80M |
| Net income applicable to common shares | - | - | - | 76.20M | 73.20M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 566.90M | 592.00M | 626.60M | 641.60M | 615.30M |
| Intangible assets | 2.10M | 2.80M | - | 5.90M | 10.50M |
| Other current assets | 2.30M | 7.30M | - | 76.00M | 0.03M |
| Total liab | 135.70M | 130.40M | 125.60M | 151.00M | 103.60M |
| Total stockholder equity | 433.50M | 461.00M | 499.00M | 488.80M | 509.20M |
| Other current liab | 1.60M | 0.30M | 4.80M | 22.20M | 4.80M |
| Common stock | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M |
| Capital stock | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M |
| Retained earnings | 375.40M | 398.00M | 432.80M | 427.20M | 445.40M |
| Other liab | - | - | - | 37.00M | 33.50M |
| Good will | 14.30M | 14.30M | - | 14.30M | 14.30M |
| Other assets | - | - | - | 22.10M | 23.10M |
| Cash | 24.20M | 29.30M | 33.40M | 58.70M | 74.90M |
| Total current liabilities | 61.60M | 45.90M | 45.70M | 84.60M | 56.00M |
| Net debt | 24.80M | 21.10M | 16.80M | -26.60M | -59.00M |
| Short term debt | 19.40M | 9.20M | 6.80M | 2.70M | 1.80M |
| Short long term debt | 17.50M | 7.50M | 5.20M | 0.90M | - |
| Short long term debt total | 49.00M | 50.40M | 50.20M | 32.10M | 15.90M |
| Other stockholder equity | 62.20M | 62.10M | 65.30M | 60.70M | 62.90M |
| Property plant equipment | - | - | - | 347.20M | 305.70M |
| Total current assets | 185.40M | 201.40M | 218.50M | 231.60M | 237.60M |
| Net tangible assets | - | - | - | 468.60M | 484.40M |
| Short term investments | - | - | 0.10M | 10.10M | 37.50M |
| Net receivables | 49.20M | 49.70M | 47.20M | 76.00M | 54.87M |
| Long term debt | 22.60M | 32.90M | 34.50M | 21.60M | 5.90M |
| Inventory | 109.70M | 115.10M | 134.50M | 86.80M | 70.30M |
| Accounts payable | 40.00M | 34.20M | 34.10M | 59.70M | 49.40M |
| Accumulated other comprehensive income | -5.00M | - | - | - | - |
| Non currrent assets other | 9.30M | 10.70M | 9.80M | 25.00M | 51.70M |
| Non current assets total | 381.50M | 390.60M | 408.10M | 410.00M | 377.70M |
| Capital lease obligations | 8.90M | 10.00M | 10.50M | 9.60M | 10.00M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Investments | 0.00M | -35.40M | -32.30M | 31.60M | -37.50M |
| Change to liabilities | - | - | - | 2.80M | 11.90M |
| Total cashflows from investing activities | -21.80M | -35.40M | - | -16.20M | -83.20M |
| Net borrowings | 0.20M | 2.70M | - | 12.40M | 3.80M |
| Total cash from financing activities | -54.60M | -51.90M | -33.70M | -82.40M | -41.70M |
| Net income | 24.90M | 15.80M | 61.00M | 75.50M | 72.80M |
| Change in cash | -5.10M | -4.10M | -25.30M | -16.20M | 1.80M |
| Begin period cash flow | 29.30M | 33.40M | 58.70M | 74.90M | 73.10M |
| End period cash flow | 24.20M | 29.30M | 33.40M | 58.70M | 74.90M |
| Total cash from operating activities | 71.10M | 84.00M | 41.70M | 80.00M | 127.10M |
| Issuance of capital stock | 0.10M | 0.20M | 0.40M | 0.40M | 6.10M |
| Depreciation | 24.90M | 23.20M | 21.50M | 21.60M | 21.90M |
| Other cashflows from investing activities | - | -2.90M | - | -2.30M | -3.80M |
| Dividends paid | 51.80M | 51.80M | 51.80M | 95.20M | 51.60M |
| Change to inventory | 5.00M | 17.20M | -50.70M | -13.40M | 26.00M |
| Change to account receivables | -4.10M | -1.70M | - | -16.90M | -18.30M |
| Sale purchase of stock | - | - | 16.00M | - | - |
| Other cashflows from financing activities | -3.10M | -3.00M | 2.60M | 12.40M | 3.80M |
| Change to netincome | - | - | - | 9.70M | 12.40M |
| Capital expenditures | 21.80M | 32.60M | 38.50M | 45.50M | 41.90M |
| Change in working capital | 6.60M | 18.00M | -48.90M | -27.50M | 19.60M |
| Stock based compensation | 3.50M | 0.20M | 1.10M | 1.80M | 1.40M |
| Other non cash items | 11.20M | 26.80M | -0.80M | 8.60M | 11.40M |
| Free cash flow | 49.30M | 51.40M | 3.20M | 34.50M | 85.20M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VCT Victrex plc |
12.00 1.33% |
911.00 | 19.13 | 12.99 | 1.82 | 1.16 | 1.77 | 8.61 |
| CRDA Croda International PLC |
19.00 0.53% |
3628.00 | 68.18 | 16.64 | 2.46 | 1.83 | 2.67 | 17.69 |
| JMAT Johnson Matthey PLC |
4.00 0.16% |
2466.00 | - | 9.44 | 0.29 | 1.53 | 0.36 | 10.76 |
| ELM Elementis PLC |
3.40 1.87% |
185.00 | 19.70 | 15.15 | 1.50 | 1.79 | 2.27 | 9.68 |
| 87FZ AECI Ltd |
-65.09 99.00% |
0.66 | 0.01 | - | 0.02 | - | - | - |
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Victrex Technology Centre, Thornton-Cleveleys, United Kingdom, FY5 4QD
44 12 5389 7700
1169
| Name | Title | Year Born |
|---|---|---|
| Jeffrey Waters | Director of Investor Relations | NA |
| Mr. Ian Clifford Melling F.C.A. | CFO & Executive Director | 1978 |
| Dr. James Mathew Routh Ph.D. | CEO & Executive Director | 1973 |
| Mr. Andrew Hanson | Director of Investor Relations, Corporate Communications & ESG | NA |
| Ms. Jane Brisley | General Counsel & Company Secretary | NA |
| Ms. Jilly Atherton | Group Human Resource Director | NA |
| Dr. John Devine Bsc Ph.D. | Managing Director for Medical | NA |
| Mr. Michael Koch | Managing Director of Sustainable Solutions | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.